APA (7th ed.) Citation

Dally, H., Bartsch, H., & Risch, A. (2003). Correspondence re: Feyler et al., Point: Myeloperoxidase −463G → a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The Myeloperoxidase −463G → a polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: 1555-1559, 2002. Cancer epidemiology, biomarkers & prevention, 12(7), .

Chicago Style (17th ed.) Citation

Dally, Heike, Helmut Bartsch, and Angela Risch. "Correspondence Re: Feyler Et Al., Point: Myeloperoxidase −463G → a Polymorphism and Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu Et Al., Counterpoint: The Myeloperoxidase −463G → a Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians. 11: 1555-1559, 2002." Cancer Epidemiology, Biomarkers & Prevention 12, no. 7 (2003).

MLA (9th ed.) Citation

Dally, Heike, et al. "Correspondence Re: Feyler Et Al., Point: Myeloperoxidase −463G → a Polymorphism and Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu Et Al., Counterpoint: The Myeloperoxidase −463G → a Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians. 11: 1555-1559, 2002." Cancer Epidemiology, Biomarkers & Prevention, vol. 12, no. 7, 2003.